(Press-News.org) A dietary supplement used to build muscle – or prevent muscle loss as a result of ageing or illness – is to be trialled as a potential treatment for chronic liver disease.
Β-hydroxy β-methylbutyrate, otherwise known as HMB, is used predominantly to build muscle bulk and function but previous studies have demonstrated it can have clinical applications.
In a new study, scientists and clinicians will test its potential to benefit some of the 60,000 people in the UK who have been diagnosed with cirrhosis, a condition that results from scarring to the liver.
In the UK, cirrhosis is most commonly caused by harmful alcohol use or fatty liver disease. In severe cases, those affected either face the prospect of a liver transplant or simply being treated for some of the symptoms of the disease.
As cirrhosis worsens, patients’ symptoms can worsen and it is estimated that the condition causes over 75,000 admissions and costs the NHS £17 billion annually.
The BOOST study will explore whether taking HMB can offer a safe and effective way of improving patients’ physical function and quality of life.
The study is being carried out by experts in liver disease, dietetics and immunology from the University of Plymouth, University of Southampton and Imperial College, London. The trial will be managed by Peninsula Clinical Trials Unit (PenCTU).
Running until 2027, it is being supported with funding of £500,000 from the Research for Patient Benefit (RfPB) programme run by the National Institute for Health and Care Research (NIHR).
In Plymouth, the project will involve members of the University’s Hepatology Research Group, NIHR ARC South West Peninsula (PenARC) and PenCTU, as well as clinicians and patients at University Hospitals Plymouth NHS Trust, which is also a sponsor of the project.
Dr Ashwin Dhanda, Associate Professor in Hepatology at the University of Plymouth and a Consultant in Hepatology at University Hospitals Plymouth NHS Trust, is the project’s Chief Investigator.
He said: “Cirrhosis is a condition that can have a significant impact on a person’s physical and mental wellbeing. But while there are treatments in development, at the moment there is nothing we can prescribe that directly addresses the condition. HMB has been identified as having the potential to fill that gap, with no suggestions at this time that there will be adverse side effects. This trial will hopefully enable us to test that fully, and establish whether HMB can indeed deliver real benefits for people with cirrhosis and those around them.”
Those leading the project also held meetings with patients diagnosed with liver cirrhosis to discuss how best to carry out the trials and to understand any particular benefits they hoped to gain from taking part.
Early this year, the study will be looking to recruit 124 patients with cirrhosis from eight hospital outpatient clinics in England, including a number in deprived areas where there are higher instances of cirrhosis.
Patients will be randomly allocated to take HMB or a placebo twice a day for 12 weeks, and then have follow-up checks for another 12 weeks.
At the start and during the trial, the researchers will measure the Liver Frailty Index, a combination of strength and function tests, and carry out other tests to examine any changes in patients’ liver disease, quality of life and mental wellbeing.
Lesley Manning has lived experience of advanced cirrhosis and has previously received a liver transplant. She is a member of the project team and will work with other people with lived experience to make sure the patient perspective is included in all aspects of running the trial.
She said: “Living with advanced cirrhosis is very debilitating. It makes you feel like you have no energy or strength, and there are no treatments out there to help manage your symptoms. I believe you need to look after yourself and the BOOST trial is testing something simple and safe that may improve the quality of life of people with advanced cirrhosis.”
END
Study explores whether dietary supplement could provide first effective treatment for cirrhosis
2025-01-28
ELSE PRESS RELEASES FROM THIS DATE:
Individual cells can be connected to plastic electrodes
2025-01-28
Researchers at Linköping University have succeeded in creating a close connection between individual cells and organic electronics. The study, published in Science Advances, lays the foundation for future treatment of neurological and other diseases with very high precision.
“We could target individual cells and explore how this affected their ability to stay healthy and functional,” says Chiara Musumeci, researcher at the Laboratory of Organic Electronics, LOE, at Linköping University.
The brain is controlled by electrical signals that are converted into chemical substances in the communication between the brain ...
University of Virginia study reveals air pollution inequities linked to industrial swine facilities are detectable from space
2025-01-28
A groundbreaking study led by researchers from the University of Virginia has used satellite measurements to show the long-term persistence of air pollution inequalities tied to industrialized swine facilities in Eastern North Carolina. Using satellite data spanning a 15-year period from 2008–2023, the study quantifies disparities in ammonia (NH₃) — an air pollutant emitted by swine operations — for Black, Hispanic and Indigenous communities. These inequalities, exacerbated by hot and calm weather ...
Cell death and aging in cancer research review
2025-01-28
Aging cells secrete substances known to promote the growth of cancer cells. The development of drugs that can selectively kill these cells or inhibit the secretion of substances is ongoing. The latest findings on the interaction between cell death and cellular senescence in cancer and their pathophysiological significance have been reviewed by a team from Osaka Metropolitan University’s Graduate School of Medicine and Harvard Medical School.
Lecturer Kouhei Shimizu and Professor Fuminori Tokunaga of OMU and Dr. Hiroyuki Inuzuka of Harvard Medical School outlined ...
Flame retardants in battery enclosures may do more harm than good
2025-01-28
As dangerous lithium-ion battery fires are on the rise, regulators and manufacturers are scrambling for solutions. Unfortunately, one common strategy may cause serious health harm and not work to slow or stop the fires. A new Viewpoint in Environmental Science & Technology explains that adding flame retardants to the plastic cases surrounding these batteries has no proven fire-safety benefit. The scientists further warn that the types of flame retardants widely used in electronics enclosures are linked to cancer and other health harms and can end up in children’s toys, food containers, and other products made from recycled plastic.
“The use of flame ...
Kenya study highlights complexity of tree-planting schemes
2025-01-28
Research with smallholder farmers in Kenya shows that tree-planting schemes must account for complex local issues and preferences.
Tree planting is central to many countries’ climate mitigation and biodiversity conservation goals, and Kenya alone plans to plant 15 billion trees by 2032.
Adding trees and shrubs to farmland (called agroforestry) can boost biodiversity, carbon storage, soil health, food production and income. But many tree-planting schemes overlook diversity and promote a narrow range of species.
The new study – led by the University of Exeter – examined the factors that enable or prevent Kenyan smallholders from increasing the diversity of ...
Transforming longevity research: AI paves the way for personalised treatments in ageing science
2025-01-28
A collaborative study between researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and the Institute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Germany, investigated how advanced AI tools, like Large Language Models (LLMs), can make it easier to evaluate interventions for ageing and provide personalised recommendations. The findings were published in the leading review journal Ageing Research Reviews.
Research into ...
Humanoid robots join human musicians for synchronized musical performances
2025-01-28
In a fascinating blend of technology and artistry, researchers present a study in PeerJ Computer Science, showcasing how humanoid robots can collaborate seamlessly with human musicians during live musical performances. This innovative work highlights the evolving role of robotics in entertainment and creativity.
The study introduces a human-robot musical band featuring Polaris, a mid-sized humanoid robot as a drummer, and Oscar, a Robotis-OP3 humanoid robot as a keyboardist. These robots performed alongside human musicians, achieving natural synchronization and ...
Regularly seeing the same GP could free up NHS appointments, research shows
2025-01-28
New research indicates that regularly seeing the same GP could reduce workload in practices and hospitals, potentially freeing up appointments for patients.
The study was conducted by Cambridge Judge Business School, University of Cambridge, the University of Exeter Medical School and St Leonard’s Practice in Exeter. The research focuses on continuity of care – whether there’s any benefit from patients seeing the same GP at most of their appointments. This continuity has been steadily decreasing in patient care since 2012, and increasingly patients see multiple GPs within a practice, or temporarily placed GPs, known as locums.
Now, the new research, published in the ...
Australian innovation ‘sifts’ space for mysteries
2025-01-28
The first trial of an Australian-developed technology has detected mysterious objects by sifting through signals from space like sand on a beach.
Astronomers and engineers at CSIRO, Australia’s national science agency, developed the specialised system, CRACO, for their ASKAP radio telescope to rapidly detect mysterious fast radio bursts and other space phenomena.
The new technology has now been put to the test by researchers led by the Curtin University node of the International Centre for Radio Astronomy ...
Senior Bowl players learn CPR, join the Nation of Lifesavers movement
2025-01-28
MOBILE, Ala., Jan. 27, 2025 — The American Heart Association and the Reese’s Senior Bowl™ teamed up to ensure more people are confident and capable when faced with a cardiac emergency. On Senior Bowl Community Service Day, Jan. 27, the potential NFL Draft prospects who have completed their college eligibility and coaches learned Hands-Only CPR and how to use an automatic external defibrillators (AED) to respond in a cardiac emergency. According to American Heart Association data, 9 out of every 10 of people who experience cardiac arrest outside of a hospital die, in part because ...